Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Discovery could help fight classical swine fever
Classical swine fever was eradicated in the US in 1978 but still plagues pork producers in China and other countries.
Scientist develops ‘safe, inexpensive’ vaccine 

New research could help China to fight classical swine fever, whilst preventing it spreading to other countries that are currently free from the disease.

This is according to a scientist from Kansas State University, who says he has developed a safe, inexpensive new vaccine. It uses a protein from the virus rather than live or attenuated virus - meaning the vaccine poses no biosecurity threat to the US.

The vaccine has been licensed to a Chinese animal health company so it can be tested in the field.

Classical swine fever was eradicated in the US in 1978 but still plagues pork producers in China and other countries. Each of the 700 million pigs raised annually in China receives two doses of the existing vaccine.

Professor Jishu Shi also discovered specific antibodies that can be used to differentiate between infected and vaccinated pigs. Animals given the current modified live virus vaccine test positive for classical swine fever. Prof Shi is working with colleagues at the US Department of Agriculture and in Europe and China to conduct further trials.

“This exciting discovery could result in solving an economic and trade problem in China - vaccines are expensive, and countries with classical swine fever can’t export pork - and a security problem for the US,” he explained.

Kansas State University’s vice president for research, Peter Dorhout, said: “Shi's work shows how we are expanding our reach around the world to build relationships, provide expertise and keep our food industries and supplies safe.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.